Cite
HARVARD Citation
Naidech, A. et al. (2022). Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. International journal of stroke. 17 (7), pp. 806-809. [Online].